← Dashboard
Nov 16, 2026 10:30 PM ET
Signal
Corporate
Interpace Biosciences GAAP EPS of -$0.26, revenue of $10.4M
Interpace Biosciences GAAP EPS of -$0.26, revenue of $10.4M
What changed
Interpace Biosciences GAAP EPS of -$0.26, revenue of $10.4M
Why it matters
Interpace Biosciences GAAP EPS of -$0.26, revenue of $10.4M — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →